Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells

Author:              

Publisher: Spandidos Publications

ISSN: 1019-6439

Source: International Journal of Oncology, Vol.44, Iss.6, 2014-01, pp. : 2132-2138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content